Eurosurveillance: Unterschied zwischen den Versionen
| [gesichtete Version] | [gesichtete Version] |
Thomas (Diskussion | Beiträge) (→Herausgeber) |
FreeW (Diskussion | Beiträge) (Div.) |
||
| Zeile 2: | Zeile 2: | ||
[https://www.eurosurveillance.org Offizielle Webseite] | [https://www.eurosurveillance.org Offizielle Webseite] | ||
| − | + | = <font style="vertical-align:inherit"><font style="vertical-align:inherit">Stellvertretende Redakteure /</font></font> Mitherausgeber = | |
| + | *'''Tommi Asikainen''', [[Europäische_Kommission|European Commission]], Brussels, Belgium ''[https://www.eurosurveillance.org/upload/site-assets/imgs/Annual_Declaration_of_Interests_for_2024_Tommi_Asikainen.pdf Declaration of Interest] ''(= Interessenerklärung) | ||
| + | *'''Magnus Boman''', Karolinska Institutet (KI), Stockholm, [[Schweden|Sweden]] ''[https://www.eurosurveillance.org/upload/site-assets/imgs/Annual_Declaration_of_Interests_for_2024_Magnus_Boman.pdf Declaration of Interest]'' | ||
| + | *[[Christian_Drosten|'''Christian Drosten''']], [[Charité|Charité]] [[Berlin|Berlin]], [[Deutschland|Germany]] ''[https://www.eurosurveillance.org/upload/site-assets/imgs/Annual_Declaration_of_Interests_for_2024_Christian_Drosten.pdf Declaration of Interest]'' | ||
| + | *'''Ole Heuer''', [[Europäisches_Zentrum_für_die_Prävention_und_die_Kontrolle_von_Krankheiten|European Centre for Disease Prevention and Control]] (ECDC), Stockholm, Sweden ''[https://www.eurosurveillance.org/upload/site-assets/imgs/Annual_Declaration_of_Interests_for_2024_Ole_Heuer.pdf Declaration of Interest]'' | ||
| + | *'''David Heymann''', London School of Hygiene & Tropical Medicine, London, [[Vereinigtes_Königreich|United Kingdom]] ''[https://www.eurosurveillance.org/upload/site-assets/imgs/Annual_Declaration_of_Interests_for_2024_David_Heymann.pdf Declaration of Interest]'' | ||
| + | *'''Susan Hopkins''', UK Health Security Agency (UKHSA), London, United Kingdom ''[https://www.eurosurveillance.org/upload/site-assets/imgs/Annual_Declaration_of_Interests_for_2022_Susan%20Hopkins.pdf Declaration of Interest]'' | ||
| + | *'''Irena Klavs''', National Institute of Public Health, Ljubljana, [[Slowenien|Slovenia]] ''[https://www.eurosurveillance.org/upload/site-assets/imgs/Annual_Declaration_of_Interests_for_2024_Irena_Klavs.pdf Declaration of Interest]'' | ||
| + | *'''Piotr Kramarz''', European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden ''[https://www.eurosurveillance.org/upload/site-assets/imgs/Annual_Declaration_of_Interests_for_2024_Piotr_Kramarz.pdf Declaration of Interest]'' | ||
| + | *'''Karl Kristinsson''', Landspitali University Hospital and University of Iceland, Reykjavik, [[Island|Iceland]] ''[https://www.eurosurveillance.org/upload/site-assets/imgs/Annual_Declaration_of_Interests_for_2024_Karl_Kristinsson.pdf Declaration of Interest]'' | ||
| + | *'''Shingai Machingaidze''', Cape Town, [[Südafrika|South Africa]] ''[https://www.eurosurveillance.org/upload/site-assets/imgs/Annual_Declaration_of_Interests_for_2024_Shingai_Machingaidze.pdf Declaration of Interest]'' | ||
| + | *'''Jacob Moran-Gilad''', Ben-Gurion University of the Negev, Beer-Sheva, [[Israel|Israel]] ''[https://www.eurosurveillance.org/upload/site-assets/imgs/Annual_Declaration_of_Interests_for_2024_Jacob_Moran-Gilad.pdf Declaration of Interest]'' | ||
| + | *'''Chantal Reusken''', Centre for Infectious Disease Control of the Dutch National Institute for Public Health and the Environment, Bilthoven, the [[Niederlande|Netherlands]] ''[https://www.eurosurveillance.org/upload/site-assets/imgs/Annual_Declaration_of_Interests_for_2024_Chantal_Reusken%20(1).pdf Declaration of Interest]'' | ||
| + | *'''Panayotis T. Tassios''', National Kapodistrian University of Athens, Athens, [[Griechenland|Greece]] ''[https://www.eurosurveillance.org/upload/site-assets/imgs/Annual_Declaration_of_Interests_for_2024_Panayotis_T._Tassios.pdf Declaration of Interest]'' | ||
| + | *'''Hélène Therre''', Santé publique France, Paris, [[Frankreich|France]] ''[https://www.eurosurveillance.org/upload/site-assets/imgs/Annual_Declaration_of_Interests_for_2024_Hélène_Therre.pdf Declaration of Interest]'' | ||
| + | *'''Henriette de Valk''', Santé publique France, Paris, France ''[https://www.eurosurveillance.org/upload/site-assets/imgs/Annual_Declaration_of_Interests_for_2024_Henriette_de_Valk.pdf Declaration of Interest]'' | ||
| + | *'''Marieke van der Werf''', European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden ''[https://www.eurosurveillance.org/upload/site-assets/imgs/Annual_Declaration_of_Interests_for_2023_Marieke_van_der_Werf.pdf Declaration of Interest]'' | ||
| + | *'''Sylvie van der Werf''', Pasteur Institute and University Paris Diderot, Paris, France ''[https://www.eurosurveillance.org/upload/site-assets/imgs/Annual_Declaration_of_Interests_for_2024_Sylvie_van_der_Werf.pdf Declaration of Interest]'' | ||
| − | == | + | Quelle<ref name="Editorial board">Eurosurveillance: [https://www.eurosurveillance.org/board Editorial board] ([https://www-eurosurveillance-org.translate.goog/board?_x_tr_sl=auto&_x_tr_tl=de&_x_tr_hl=de&_x_tr_pto=wapp Übersetzung] durch [[Google]])</ref> |
| − | + | = Redaktionelle Berater = | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | [ | + | *… |
| + | *[[Deutschland|Deutschland]]: [[Jamela_Seedat|Jamela Seedat]], [[Robert_Koch-Institut|Robert_Koch-Institut]], Berlin | ||
| + | *… | ||
| − | == | + | Quelle<ref name="Editorial board">Eurosurveillance: [https://www.eurosurveillance.org/board Editorial board] ([https://www-eurosurveillance-org.translate.goog/board?_x_tr_sl=auto&_x_tr_tl=de&_x_tr_hl=de&_x_tr_pto=wapp Übersetzung] durch [[Google]])</ref> |
| − | + | = Veröffentlichung = | |
| − | + | *[[Detection_of_2019_novel_coronavirus_(2019-nCoV)_by_real-time_RT-PCR|Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR]] | |
| − | == | + | = Siehe auch = |
| − | * [[ | + | |
| + | *[[PCR-Test|PCR-Test]] | ||
[[Category:COVID19]] | [[Category:COVID19]] | ||
Version vom 5. November 2024, 01:46 Uhr
Inhaltsverzeichnis
Stellvertretende Redakteure / Mitherausgeber
- Tommi Asikainen, European Commission, Brussels, Belgium Declaration of Interest (= Interessenerklärung)
- Magnus Boman, Karolinska Institutet (KI), Stockholm, Sweden Declaration of Interest
- Christian Drosten, Charité Berlin, Germany Declaration of Interest
- Ole Heuer, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden Declaration of Interest
- David Heymann, London School of Hygiene & Tropical Medicine, London, United Kingdom Declaration of Interest
- Susan Hopkins, UK Health Security Agency (UKHSA), London, United Kingdom Declaration of Interest
- Irena Klavs, National Institute of Public Health, Ljubljana, Slovenia Declaration of Interest
- Piotr Kramarz, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden Declaration of Interest
- Karl Kristinsson, Landspitali University Hospital and University of Iceland, Reykjavik, Iceland Declaration of Interest
- Shingai Machingaidze, Cape Town, South Africa Declaration of Interest
- Jacob Moran-Gilad, Ben-Gurion University of the Negev, Beer-Sheva, Israel Declaration of Interest
- Chantal Reusken, Centre for Infectious Disease Control of the Dutch National Institute for Public Health and the Environment, Bilthoven, the Netherlands Declaration of Interest
- Panayotis T. Tassios, National Kapodistrian University of Athens, Athens, Greece Declaration of Interest
- Hélène Therre, Santé publique France, Paris, France Declaration of Interest
- Henriette de Valk, Santé publique France, Paris, France Declaration of Interest
- Marieke van der Werf, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden Declaration of Interest
- Sylvie van der Werf, Pasteur Institute and University Paris Diderot, Paris, France Declaration of Interest
Quelle[1]
Redaktionelle Berater
- …
- Deutschland: Jamela Seedat, Robert_Koch-Institut, Berlin
- …
Quelle[1]
